Management of Parkinson's disease - The Pharmaceutical Journal - The Pharmaceutical Journal

Parkinson’s disease (PD) is a chronic neurodegenerative disorder, first described in 1817 in ‘An essay on the shaking palsy’ by surgeon James Parkinson. It is caused by the loss of dopamine-containing cells in the substantia nigra. Dopamine is critical to mov…

After reading this article, you should be able to: Parkinsons disease (PD) is a chronic neurodegenerative disorder, first described in 1817 in ‘An essay on the shaking palsy’ by surgeon James Parkin… [+26234 chars]

full article...